Archive | Redefining Every Stage Investments (RESI) RSS feed for this section

RESI Panel Announcement: Explore Houston’s Innovation Drive in The Future Is Now

7 Apr

By Lucy Parkinson, Director of Research, LSN

Houston is on a roll in life science technology. In 2015, the TMCx Accelerator ran its debut class of new healthcare companies; 2016 has already seen the arrival of JLABS@TMC, and AT&T Foundry will open in Houston soon. These facilities will collectively support dozens of new healthcare inventions, fostering a diverse ecosystem of early stage life science companies in Houston. This RESI panel, The Future Is Now, will cover these new developments and explain why Houston’s moment for has come.

Moderated by Nicole Fisher, Founder & CEO, HHR Strategies, the panel will feature:

This unique session will explore how Houston has become a health innovation hub that attracts major strategic firms to open facilities for entrepreneurs. The participants will also describe the innovation that’s happening at their new facilities in Houston, how they’re supporting new technologies that are coming out of Texas Medical Center’s instutitions, and what kinds of innovators they’re looking to work with.

If you’d like to be there in person, it’s not too late to sign up to join RESI@TMCx.

RESI-Houston-2016_600

Redefining Early Stage Investments (RESI) Conference…Get On Board the Investor Train

31 Mar

By Dennis Ford, Founder & CEO, LSN

dennis-websit

When LSN founded the Redefining Early Stage Investments (RESI) conference in 2013, it was with the simple hope of creating an event that offered more to early stage life science investors and CEOs than the other partnering events that existed at the time. LSN’s business development team had visited partnering events and investor conferences throughout the USA and also internationally, and had met few active early stage investors at these events. As LSN began to cultivate relationships with these firms and discover what kinds of technologies they were seeking to invest in, we saw the opportunity to create an event that would bring these investors together to meet with fundraising CEOs whose technologies matched their investment mandates.

We’re now approaching the 8th RESI event, and over the last three years thousands of entrepreneurs and investors have come face to face at RESI to talk about new healthcare technologies. RESI has picked up the pace every year, becoming a quarterly event for the first time in 2016.

Not only that, but RESI has hit the road; following three successful RESI events in Boston, LSN saw the opportunity to host RESI in San Francisco during the annual healthcare conference week. Organizing an event so far from our home office in Boston was a tremendous challenge that took LSN beyond our previous comfort zone, but we found that RESI was well received as a part of the annual JPM ecosystem, filling a niche for early stage companies and investors that had previously been lacking in a conference week that’s primarily geared to later stage and publicly traded companies.

Last year, RESI also expanded to Houston as a part of Texas Medical Center’s efforts to build a “Third Coast” for healthcare innovation, supported by the resources, expertise and discoveries made at their member institutions. Houston has also attracted many other strategic partners to this effort, including Johnson & Johnson’s JLABS. Being in the right place at the right time is a gift in any innovative technology endeavor, and recognizing that RESI and JLABS are now coinciding in [geography], JLABS became RESI’s title sponsor.

This summer, RESI will take another step: the first international event, held at MaRS in Toronto on June 23rd. As we’ve added new events to the RESI circuit, we’ve brought new faces into LSN’s informal network at every new venue and uncovered the unique strengths and needs of each area.

So how have we continued to build RESI’s value? One question we typically ask fundraising CEOs is how many investor meetings they’ve had in the last year. We might typically hear they’ve pitched to a dozen or more investors in one year. RESI provides an opportunity to participate in both scheduled and ad hoc meetings, and many CEOs report up to 16 -20 meetings in one day, four times per year, with active investors who are a fit for their opportunity. With the potential for over 80 meetings for those that attend every event, there aren’t any other events that offer a comparable return on effort for a CEO on the road looking for development capital. And after 7 successful events, we’ve heard from many investors that they’ve conducted due diligence on companies that they’ve met at RESI.

LSN is looking ahead to a busy year for RESI, with events lined up in Houston (April 11th), Toronto (June 23rd) and Boston (September 13th) for our ever-expanding network to come together. We’re excited to be breaking new ground and hope you’ll join us on this global investor circuit.

RESI-Houston-2016_600

RESI Panel Announcement: Family Offices

31 Mar

By Lucy Parkinson, Director of Research, LSN

Family offices often catch the interest of entrepreneurs due to the possibility of committed, long-term capital from investors who look to the long view regarding their investment decisions.  Family offices may also have unique investment motivations that relate to the family’s particular expertise and history.  With a reputation for being deep-pocketed and flexible investors, life science CEOs are often interested in meeting with family office investors, and this panel will allow the RESI@TMCx audience to learn directly from family office investment staff about how they invest, what they look for in a life science opportunity, and how to find alignment with their needs.

Moderated by Colin Widen, CEO, Boston Innovation Capital, the panelists are:

If you’re interested in listening to this panel live at RESI, you can register for RESI@TMCx now.

RESI-Houston-2016_600

RESI Panel Announcement: Healthcare System Partners

31 Mar

By Shaoyu Chang, MD, MPH, Senior Research Manager, LSN

Shaoyu 10*10

The RESI team is pleased to debut a new panel on Healthcare System Partners at RESI@TMCx on April 11. In an article titled “Innovation as Discipline, Not Fad,” the New England Journal of Medicine called on healthcare organizations to embrace innovations and serve as the training ground to test their medical benefits, technical feasibility, and business viability. Many healthcare systems are doing just that. This panel will reveal the changing role healthcare organizations are playing in fostering innovation.

Moderated by Rebecca Kaul, Chief Innovation Officer, MD Anderson, this session will feature:

From innovation centers to investment vehicles, healthcare organizations have become critical partners for entrepreneurs. Whether you are considering generating user experience, conducting pilot studies, or receiving technical guidance, the value of face-to-face meetings with these institutions is unfathomable. At the heart of the world’s largest medical center, this panel will help entrepreneurs navigate complex healthcare systems and bring their companies to the next milestone.

Registering for the RESI Conference will give you the opportunity to listen to this panel live, connect with relevant investors and network with like-minded entrepreneurs.

RESI-Houston-2016_600

Top Takeaways for Pitching from the WIB, JLABS, and J&J Innovation Lobster Pot

24 Mar

By Christine A. Wu, Research Analyst, LSN

chrsitine

The Lobster Pot was boiling last Wednesday at the Women in Bio and Johnson & Johnson Innovation Shark Tank-style pitch event in Cambridge, MA. Organized by the LSN team, eight female life science CEOs gave 6-minute pitches proceeded by short sessions of feedback from five female investors.

So how hot did the “chef” investors boil these “lobster” CEOs? Below are common critiques to fundraising entrepreneurs – be sure to take these into account for your next presentation.DSC03757

Address your Audience

Keep in mind who your audience is and tailor your message appropriately. Take into account their background and expertise – what do they already know? What areas require more explanation? Does the audience already know your target market? Will the audience understand you? Often times, the entrepreneur will take a longer time to explain the overall market when the investor is already familiar and instead wants other questions to be answered (i.e. the science and data, management team, revenue generation, etc.). Especially if your audience has a scientific background, be sure to include your mechanism of action if developing a therapeutic product. Knowing your audience will give you a better idea of what can be briefly addressed and where to delve deeper.

Address the Patient Impact

Take a step back from your clinical evidence and remember to give a broad overview of what this all means for the patient population. What are you trying to change? Think about compliance, symptom monitoring, reimbursement, your endpoint. How are the patients going to use your technology and how will it change their everyday lives?

Explain how to get to the Provider(s)

It’s important for investors to know how the technology gets into an actionable set of hands. Look past the fundraising and commercialization process and answer how the technology will be ultimately distributed, analyzed, and utilized. If you are developing a direct to consumer technology, make sure to mention the pricing and distribution model along with regulatory involvement. Furthermore, you need to address how to convince physicians to give up their current gold standards of care, especially if you’re in an established disease market. Additionally, if developing a diagnostic, be sure to address how you control false negatives – how comfortable are you and how comfortable will the physician be with its diagnosis/validation?

Include your Development Timeline

You should summarize your entire development timeline in one easy slide. This includes the reimbursement pathway; the FDA regulatory process and approval; the clinical trials and commercialization strategy; and where you currently lie.

Include how much you are currently fundraising, what milestone it will get you to, and the future inflection points. If your technology is currently on-the-market, include its revenue generation.

Keep your Slides Simple

Slides should be easy on the eyes. A common critique was that slides had too many words, not enough visuals, and that slides can often times be consolidated. Can the audience look at your slide and know your point in just a few seconds? It was also advised to know your pre-money valuation, but not to include in your slides, as it would likely be as high as you will get and more difficult to negotiate down the road.

Address your Competitors & Strategic Partners

You must address who your competitors are upfront. Demonstrate how the technology compares to anything else being developed and on the market. On the other end of the spectrum, include who might be strategic partners. These will demonstrate your knowledge of your market segment in its entirety.

Show your Management Team & Advisers

Be sure to acknowledge your team and the experience behind it. Who is supporting you and who are your advisers behind the scenes? Show off your team as thoroughly as you can.

Practice your Pitch

Deliver your overall vision at the start – be sure to nail down the introduction. You should start with the problem; how it is treated today; what’s wrong with the current therapy; and how you are addressing it. If under a time crunch, practice your pace. You should be clear and direct. Let your passion come through the presentation and show ownership in its delivery.

DSC03765

RESI@TMCx Panel Announcement: Diagnostic Investors

24 Mar

By Cole Bunn, Research Analyst, LSN

cole-wp

The diagnostics space encompasses a very wide range of technologies targeting indications across the board, and is arguably the most difficult sector, under the life science umbrella, to successfully navigate. Not only do these entrepreneurs have to first identify the correct capital providers and strategic partners to make their technologies a commercial reality, like everyone else, but piquing the interests of those entities may be considerably more difficult. Oftentimes, clearly articulating the value proposition of your diagnostic product/service is a little trickier than that of a more traditional therapeutic or medical device, and the go-to-market strategy for these technologies will usually be more highly scrutinized.

Moderated by John Walter, CEO & President, Alliance for Cancer Gene Therapy Foundation, this session will feature:

Given the complex strategic landscape diagnostics often face, along with the importance of the having the correct strategy in place, the value of guidance and feedback from experienced diagnostic investors can’t be overstated. This diverse set of panelists, representing a variety of different funds and organizations, will give the audience firsthand perspectives to help position their companies for success.

Registering for the RESI Conference will give you the opportunity to listen to this panel live, connect with relevant investors and network with like-minded entrepreneurs.

RESI@TMCx Panel: Medical Device Investors Share Their Strategies

24 Mar

By Lucy Parkinson, Director of Research, LSN

Medtech innovation is one of the focuses of Texas Medical Center’s innovation programs, with TMCx focusing its startup acceleration program on medical devices and healthcare IT. RESI@TMCx will provide a venue for investors to meet with innovative medical device startups from Texas and beyond, and this panel session will explore what it takes to get a new device product funded and commercialized.

Moderated by Angela Shah, Editor, Xconomy, the panelists are:

The panelists will share their experience and insight on the medical device sector, including what areas of medical technology are of peak interest right now, what factors they examine when performing diligence on a medical device company, and what opportunities they see for the future of device innovation. If you’d like to hear from these experienced investors and from our expert moderator, you can register for RESI now.